These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 38062036)
21. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Lodi R; Cooper JM; Bradley JL; Manners D; Styles P; Taylor DJ; Schapira AH Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11492-5. PubMed ID: 10500204 [TBL] [Abstract][Full Text] [Related]
22. Skeletal Muscle Involvement in Friedreich Ataxia. Indelicato E; Wanschitz J; Löscher W; Boesch S Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337401 [TBL] [Abstract][Full Text] [Related]
23. Mitochondrial frataxin interacts with ISD11 of the NFS1/ISCU complex and multiple mitochondrial chaperones. Shan Y; Napoli E; Cortopassi G Hum Mol Genet; 2007 Apr; 16(8):929-41. PubMed ID: 17331979 [TBL] [Abstract][Full Text] [Related]
24. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures. Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117 [TBL] [Abstract][Full Text] [Related]
25. The first cellular models based on frataxin missense mutations that reproduce spontaneously the defects associated with Friedreich ataxia. Calmels N; Schmucker S; Wattenhofer-Donzé M; Martelli A; Vaucamps N; Reutenauer L; Messaddeq N; Bouton C; Koenig M; Puccio H PLoS One; 2009 Jul; 4(7):e6379. PubMed ID: 19629184 [TBL] [Abstract][Full Text] [Related]
26. Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model. Tomassini B; Arcuri G; Fortuni S; Sandi C; Ezzatizadeh V; Casali C; Condò I; Malisan F; Al-Mahdawi S; Pook M; Testi R Hum Mol Genet; 2012 Jul; 21(13):2855-61. PubMed ID: 22447512 [TBL] [Abstract][Full Text] [Related]
27. Effect of Mitochondrial and Cytosolic FXN Isoform Expression on Mitochondrial Dynamics and Metabolism. Agrò M; Díaz-Nido J Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158039 [TBL] [Abstract][Full Text] [Related]
28. The in vivo mitochondrial two-step maturation of human frataxin. Schmucker S; Argentini M; Carelle-Calmels N; Martelli A; Puccio H Hum Mol Genet; 2008 Nov; 17(22):3521-31. PubMed ID: 18725397 [TBL] [Abstract][Full Text] [Related]
29. Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts. Khonsari H; Schneider M; Al-Mahdawi S; Chianea YG; Themis M; Parris C; Pook MA; Themis M Gene Ther; 2016 Dec; 23(12):846-856. PubMed ID: 27518705 [TBL] [Abstract][Full Text] [Related]
30. The Regulation of the Disease-Causing Gene Dong YN; Mercado-Ayón E; Coulman J; Flatley L; Ngaba LV; Adeshina MW; Lynch DR Cells; 2024 Jun; 13(12):. PubMed ID: 38920668 [TBL] [Abstract][Full Text] [Related]
31. Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia. Vaubel RA; Isaya G Mol Cell Neurosci; 2013 Jul; 55():50-61. PubMed ID: 22917739 [TBL] [Abstract][Full Text] [Related]
32. Iron metabolism and mitochondrial abnormalities in Friedreich ataxia. Pandolfo M Blood Cells Mol Dis; 2002; 29(3):536-47; discussion 548-52. PubMed ID: 12547248 [TBL] [Abstract][Full Text] [Related]
33. Genetic variations creating microRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia. Bandiera S; Cartault F; Jannot AS; Hatem E; Girard M; Rifai L; Loiseau C; Munnich A; Lyonnet S; Henrion-Caude A PLoS One; 2013; 8(1):e54791. PubMed ID: 23382970 [TBL] [Abstract][Full Text] [Related]
34. Small molecules affecting transcription in Friedreich ataxia. Gottesfeld JM Pharmacol Ther; 2007 Nov; 116(2):236-48. PubMed ID: 17826840 [TBL] [Abstract][Full Text] [Related]
35. Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen. Calmels N; Seznec H; Villa P; Reutenauer L; Hibert M; Haiech J; Rustin P; Koenig M; Puccio H BMC Neurol; 2009 Aug; 9():46. PubMed ID: 19703283 [TBL] [Abstract][Full Text] [Related]
36. Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia-associated diabetes. Cnop M; Igoillo-Esteve M; Rai M; Begu A; Serroukh Y; Depondt C; Musuaya AE; Marhfour I; Ladrière L; Moles Lopez X; Lefkaditis D; Moore F; Brion JP; Cooper JM; Schapira AH; Clark A; Koeppen AH; Marchetti P; Pandolfo M; Eizirik DL; Féry F Ann Neurol; 2012 Dec; 72(6):971-82. PubMed ID: 23280845 [TBL] [Abstract][Full Text] [Related]
37. Altered nucleosome positioning at the transcription start site and deficient transcriptional initiation in Friedreich ataxia. Chutake YK; Costello WN; Lam C; Bidichandani SI J Biol Chem; 2014 May; 289(22):15194-202. PubMed ID: 24737321 [TBL] [Abstract][Full Text] [Related]
38. Friedreich's ataxia: past, present and future. Marmolino D Brain Res Rev; 2011 Jun; 67(1-2):311-30. PubMed ID: 21550666 [TBL] [Abstract][Full Text] [Related]
39. Frataxin gene point mutations in Italian Friedreich ataxia patients. Gellera C; Castellotti B; Mariotti C; Mineri R; Seveso V; Didonato S; Taroni F Neurogenetics; 2007 Nov; 8(4):289-99. PubMed ID: 17703324 [TBL] [Abstract][Full Text] [Related]
40. Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations. Medina-Carbonero M; Sanz-Alcázar A; Britti E; Delaspre F; Cabiscol E; Ros J; Tamarit J Cell Mol Life Sci; 2022 Jan; 79(2):74. PubMed ID: 35038030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]